Pivotal Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) or HEARTLIGHT for the Treatment of Symptomatic Atrial Fibrillation
Location:
Jacksonville, Fla., Rochester, Minn.
Trial status:
Open for Enrollment
Why is this study being done?
A randomized, controlled trial designed to demonstrate the safety and effectiveness of the experimental device to deliver pulmonary vein isolation as a treatment for symptomatic atrial fibrillation.
NCT ID:
NCT01456000
Who can I contact for additional information about this study?
Rochester: Kristi Monahan, RN 507-255-6676
Jacksonville: Barbara Little, RN, BSN 904-953-8361